Back
Y-mAbs Therapeutics Stock Price Chart
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Buy
60
YMAB
Y-mAbs Therapeutics
Last Price:
14.68
Seasonality Move:
22.25%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly- The current trend is moderately bearish and YMAB is experiencing slight selling pressure.
Y-mAbs Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.07 | Sell |
| 20-day SMA: | 14.82 | Sell |
| 50-day SMA: | 15.74 | Sell |
| 200-day SMA: | 9.01 | Buy |
| 8-day EMA: | 14.97 | Sell |
| 20-day EMA: | 15.03 | Sell |
| 50-day EMA: | 14.63 | Buy |
| 200-day EMA: | 10.77 | Buy |
Y-mAbs Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 46.02 | Sell |
| Chaikin Money Flow: | -15320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.38 - 15.76) | Sell |
| Bollinger Bands (100): | (8.52 - 16.4) | Buy |
Y-mAbs Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Y-mAbs Therapeutics Stock
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 14.71 while YMAB 8-day simple moving average is 15.07, which is a Sell signal.
- The stock price of YMAB is 14.71 while Y-mAbs Therapeutics 20-day SMA is 14.82, which makes it a Sell.
- Y-mAbs Therapeutics 50-day simple moving average is 15.74 while YMAB share price is 14.71, making it a Sell technically.
- YMAB stock price is 14.71 and Y-mAbs Therapeutics 200-day simple moving average is 9.01, creating a Buy signal.
YMAB Technical Analysis vs Fundamental Analysis
Buy
60
Y-mAbs Therapeutics (YMAB)
is a Buy
Is Y-mAbs Therapeutics a Buy or a Sell?
-
Y-mAbs Therapeutics stock is rated a Buy
The current Y-mAbs Therapeutics [YMAB] share price is $14.71. The Score for YMAB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Y-mAbs Therapeutics Stock Info
Market Cap:
643.96M
Price in USD:
14.71
Share Volume:
189.35K
Y-mAbs Therapeutics 52-Week Range
52-Week High:
20.90
52-Week Low:
4.60
Buy
60
Y-mAbs Therapeutics (YMAB)
is a Buy
Y-mAbs Therapeutics Share Price Forecast
-
What is the Y-mAbs Therapeutics stock price today?
The Y-mAbs Therapeutics stock price is 14.71 USD today. -
Will YMAB stock go up or go down?
Y-mAbs Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Y-mAbs Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Y-mAbs Therapeutics is not overvalued.
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 14.71 while YMAB 8-day exponential moving average is 14.97, which is a Sell signal.
- The stock price of YMAB is 14.71 while Y-mAbs Therapeutics 20-day EMA is 15.03, which makes it a Sell.
- Y-mAbs Therapeutics 50-day exponential moving average is 14.63 while YMAB share price is 14.71, making it a Buy technically.
- YMAB stock price is 14.71 and Y-mAbs Therapeutics 200-day simple moving average is 10.77, creating a Buy signal.
Fundamental Analysis of Y-mAbs Therapeutics
Is Y-mAbs Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.27 per share.
Technical Analysis of Y-mAbs Therapeutics
Should I short Y-mAbs Therapeutics stock?
- YMAB Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Y-mAbs Therapeutics is a Sell
- Y-mAbs Therapeutics Relative Strength Index (RSI) is 46.02, which suggest Y-mAbs Therapeutics is oversold
- The Bollinger Bands (25) for Y-mAbs Therapeutics is (14.38 - 15.76), which suggest Y-mAbs Therapeutics is a Buy
- The Bollinger Bands (100) for Y-mAbs Therapeutics is (8.52 - 16.4), which suggest Y-mAbs Therapeutics is a Buy
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.